Predictors of adherence to isoniazid preventive therapy among hiv positive adults in addis ababa, ethiopia

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Mindachew, Mesele ^a   Deribew, Amare ^a   Tessema, Fasil ^a   Biadgilign, Sibhatu ^a  

^a JIMMA UNIVERSITY   (Ethiopia)

Author keywords

Adherence; Ethiopia; HIV; Isoniazid Preventive Therapy; TB

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; ETHIOPIA; FEMALE; FORECASTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIMARY PREVENTION; QUESTIONNAIRE; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; ETHIOPIA; FEMALE; FORECASTING; HIV SEROPOSITIVITY; HUMANS; INTERVIEWS AS TOPIC; ISONIAZID; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIMARY PREVENTION; QUESTIONNAIRES; TUBERCULOSIS; YOUNG ADULT;

EID: 83155191069     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-916     Document Type: Article

References (45)

1. An out breaks of tuberculosis with accelerated progression among person infected with HIV. Smoll M, Shafer F, New Engl J Med 2006 326 213 35
2. World Health Organization (WHO), Global Tuberculosis Control - surveillance, Planning, Financing WHO/HTM/TB/2006.362. Geneva: WHO 2006
3. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC, JAMA 2005 293 2767 75 10.1001/jama.293.22.2767 15941807 (Pubitemid 40965089)
4. AIDS in Ethiopia, disease prevention and control department of ministry of health. MOH, 4 2008
5. Fixed-dose combinations of anti tuberculosis medications to prevent drug resistance. Moulding T, Dutt A, Reichman L, Ann Intern Med 2006 122 951 54
6. WHO/UNAIDS, Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV.WHO/TB/98.255 Geneva: WHO 2005
7. MOH, Implementation Guidelines for TB/HIV Collaborative Activities in Ethiopia Addis Ababa: Federal Ministry of Health 2008
8. Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Program on AIDS and the Tuberculosis Program of the World Health Organization (WHO). International Union against Tuberculosis and Lung Disease, Global Program on AIDS, World Health Organization, Tubercle Lung Dis 1994 75 96 98
9. Compliance in clinical trials. Besch CL, AIDS 2004 9 1 1 10
10. Adherence to IPT among HIV infected person in Chaiang Rai Thailand. Winkvist A, Diwan V, AIDS 2007 11 107 112
11. Adherence to tuberculosis preventive therapy for people live with HIV; the example of Uganda. Foster S, Godfry-Faussett P, Porter, Modeiling J, AIDS 2002 11 3 919 925 (Pubitemid 27226416)
12. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Rowe K, Makhubele J, Hargreaves R, Int J Tuberc Lung Dis 2005 9 3 263 269 15786888 (Pubitemid 40392940)
13. INH preventive therapy among adult HIV-infected patients in Thailand. Hiransuthikul N, Nelson KE, Hiransuthikul P, Vorayingyong A, Paewplot R, Int J Tuberc Lung Dis 2005 9 3 270 5 15786889 (Pubitemid 40392941)
14. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, McCarthy AE, BMC Infect Dis 2006 13:6 97
15. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomized placebo controlled trials. Wilkinson D, BMJ 2005 317 625 629
16. Effects of previous medication experience and health beliefs on intended compliance to an imagined regimen. McCallum R, J Compliance in Health Care 2007 3 125 134 10.1111/j.1365-2524.1995.tb00013.x
17. Meichenbaum D, Turk D, Facilitating Treatment Adherence: A Practioner's Guidebook New York: Plenum Press 2006
18. Patient choice promotes adherence in preventive treatment for latent tuberculosis. Rennie TW, Bothamley GH, Engova D, Bates IP, Eur Respir J 2007 30 728 735 10.1183/09031936.00034007 17626113 (Pubitemid 351194834)
19. Predictors of patient adherence: patient characteristics. Dunbar J, The Handbook of Health Behavior Change New York: Springer, Shumaker S, Schroon E, Ockene J, 2004 348 360
20. The effects of physician communications skills on patient satisfaction; recall, and adherence. Bartlett EE, J Chronic Dis 2001 37 9-10 755 64
21. The patient-physician relationship: compliance revisited. Sbarbaro JA, Ann Allergy 2006 64 4 325 31
22. Impact of education for physicians on patient outcomes. Clark NM, Pediatrics 2004 101 5 831 6
23. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Clark NM, Eur Respir J 2000 16 1 15 21 10.1034/j.1399-3003.2000.16a04.x 10933079 (Pubitemid 30480122)
24. Effective physician-patient communication and health outcomes: a review. Stewart MA, Can Med Assoc J 2006 152 9 1423 33
25. Patient-centered consultations and outcomes in primary care: a review of the literature. Mead N, Bower P, Patient Educ Couns 2002 48 1 51 61 10.1016/S0738-3991(02)00099-X 12220750 (Pubitemid 36151681)
26. Doctor-patient communication. Korsch BM, Negrete VF, Sci Am 2003 227 2 66 74
27. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J, BMC Health Serv Res 2009 9 169 10.1186/1472-6963-9-169 19765290
28. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Munseri PJ, Talbot EA, Mtei L, Fordham von Reyn C, Int J Tuberc Lung Dis 2008 12 1037 1041 18713501
29. Use of isoniazid for latent tuberculosis infection in a public health clinic. Philip A, LoBue, Kathleen S, Moser, Am J Respir Crit Care Med 2003 168 443 447 10.1164/rccm.200303-390OC 12746255 (Pubitemid 37046873)
30. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis. Page KR, Sifakis F, Montes de Oca R, et al. Arch Intern Med 2006 166 1863 1870 10.1001/archinte.166.17.1863 17000943 (Pubitemid 44455169)
31. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island. Kwara A, Herold JS, Machan JT, Carter EJ, Chest 2008 133 4 862 8 10.1378/chest.07-2024 18071014 (Pubitemid 351536859)
32. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Horne R, Weinman J, J Psychoomat Res 1999 47 555 567 10.1016/S0022-3999(99)00057-4 (Pubitemid 30029305)
33. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Hirsch-Moverman Y, Bethel J, Colson PW, Franks J, El-Sadr W, Int J Tuberc Lung Dis 2010 14 1104 11 20819254
34. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients. Naing NN, D'Este C, Isa AR, Salleh R, Bakar N, Mahmod MR, Southeast Asian J Trop Med Public Health 2001 32 2 369 82 11556591 (Pubitemid 33641791)
35. Predictors of failure to complete treatment for latent tuberculosis infection. Parsyan AE, Saukkonen J, Barry MA, Sharnprapai S, Horsburgh CR Jr, J Infect 2007 54 262 266 10.1016/j.jinf.2006.04.010 16772095 (Pubitemid 46238167)
36. Predicting non- completion of treatment for latent tuberculosis infection: a prospective survey. Shieh FK, Snyder G, Horsburgh CR, Bernardo J, Murphy C, Saukkonen JJ, Am J Respir Crit Care Med 2006 174 717 721 10.1164/rccm.200510-1667OC 16809632 (Pubitemid 44395341)
37. Patient compliance with health regimens. Rosenstock IM, JAMA 1975 234 402 3 10.1001/jama.1975.03260170038022 1174372
38. An assessment of default and non-compliance in tuberculosis control in Pakistan. Sloan JP, Sloan MC, Trans R Soc Trop Med Hyg 1981 75 717 8 10.1016/0035-9203(81)90161-9 7330927
39. What is the successful doctor-patient interview? A study of interactions and outcomes. Stewart MA, Soc Sci Med 1984 19 167 75 10.1016/0277-9536(84)90284- 3 6474233
40. In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India. Barnhoorn F, Adriaanse H, Soc Sci Med 1992 34 3 291 306 10.1016/0277-9536(92)90271-Q 1557670
41. Compliance with drug treatment. O'Hanrahan M, O'Malley K, Br Med J 283 298 300
42. Compliance with isoniazid prophylaxis in jail. Alcabes P, Am Rev Respir Dis 2006 140 5 1194 7
43. Factors associated with compliance in treatment of tuberculosis. Menzies R, Rocher I, Vissandjee B, Tuber Lung Dis 2002 74 1 32 7
44. The Health Belief Model: a decade later. Janz NK, Becker MH, Health Educ Q 2004 11 1 1 47
45. The health belief model and personal behavior. Becker M, Health Educ Monogr 2000 1 324 508